GD2抗体达妥昔单抗β治疗神经母细胞瘤护理专家共识

打开文本图片集

Expert consensus on GD2 antibody dinutuximab beta for neuroblastoma care

WANG Chunli， WU Ying， HE Mengxue， SU Ling， ZHANG Hongyan， GUO Xin， CHENG Fangfang， LI Dan， SUN Dan， WANG Cui

Beijing Children's Hospital， Capital Medical University/National Center for Children's Health， Beijing 100045 China

Corresponding Author  WANG Chunli， E⁃mail： chunliwang2008@163.com

Abstract  Based on clinical research reports in China and abroad，as well as clinical practice experience of the participants in this study，relevant content on ganglioside⁃2（GD2） antibody dinutuximab beta for neuroblastoma care was thoroughly investigated through literature analysis，expert inquiries，and expert discussions.The final expert consensus on the use of GD2 antibody dinutuximab beta for neuroblastoma care  was formed，which included preparation and requirements，drug configuration，drug infusion，care during infusion，and observation and care of adverse reactions.

Keywords    neuroblastoma， NB； gangliosid⁃2， GD2； datuximab beta； nursing； expert consensus

摘要  基于国内外临床研究报告以及本研究参与人员临床实践经验，通过文献分析、专家函询及专家研讨对神经节苷脂⁃2（GD2）抗体达妥昔单抗β治疗神经母细胞瘤的相关内容进行深入研究，最终形成包括准备以及要求、药品配制、药品输注、输注期间护理以及不良反应观察与护理等内容的GD2抗体达妥昔单抗β治疗神经母细胞瘤护理专家共识。（剩余19354字）